SETTING: In Africa, 10% of human immunodeficiency virus (HIV) infected adults starting antiretroviral therapy (ART) die within the first year, and tuberculosis (TB) is the leading cause of death. OBJECTIVE: To investigate the predictors of ART-associated TB at an adult HIV clinic in Tanzania. DESIGN: In this nested case-control study, adults starting ART were screened for TB according to the World Health Organization protocol. Those not diagnosed with TB were observed for 6 months. Patients diagnosed with TB were defined as cases, and controls were selected from among the patients who did not develop TB using incidence density matching. RESULTS: Among the 2514 HIV-positive adults in our cohort, 72 (3%) were diagnosed with TB during the first 6 months of ART. By multivariate analysis, baseline characteristics predictive of TB were cough, fever and night sweats; 76% (55/72) of the cases had at least one of these symptoms at the time of starting ART. CONCLUSION: Overall, 75% of the patients who developed TB during the first 6 months of ART had TB symptoms at the time of starting ART. Improved TB diagnostics and/or better strategies for empirical anti-tuberculosis treatment are needed for patients with symptoms of TB at ART initiation.
SETTING: In Africa, 10% of human immunodeficiency virus (HIV) infected adults starting antiretroviral therapy (ART) die within the first year, and tuberculosis (TB) is the leading cause of death. OBJECTIVE: To investigate the predictors of ART-associated TB at an adult HIV clinic in Tanzania. DESIGN: In this nested case-control study, adults starting ART were screened for TB according to the World Health Organization protocol. Those not diagnosed with TB were observed for 6 months. Patients diagnosed with TB were defined as cases, and controls were selected from among the patients who did not develop TB using incidence density matching. RESULTS: Among the 2514 HIV-positive adults in our cohort, 72 (3%) were diagnosed with TB during the first 6 months of ART. By multivariate analysis, baseline characteristics predictive of TB were cough, fever and night sweats; 76% (55/72) of the cases had at least one of these symptoms at the time of starting ART. CONCLUSION: Overall, 75% of the patients who developed TB during the first 6 months of ART had TB symptoms at the time of starting ART. Improved TB diagnostics and/or better strategies for empirical anti-tuberculosis treatment are needed for patients with symptoms of TB at ART initiation.
Authors: Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon Journal: Am J Respir Crit Care Med Date: 2003-02-15 Impact factor: 21.405
Authors: Maryline M B Bonnet; Loretxu L P Pinoges; Francis F V Varaine; Barbara B O Oberhauser; Daniel D O O'Brien; Yared Y K Kebede; Cathy C H Hewison; Rony R Z Zachariah; Laurent L F Ferradini Journal: AIDS Date: 2006-06-12 Impact factor: 4.177
Authors: Lillian Mtei; Mecky Matee; Oliver Herfort; Muhammad Bakari; C Robert Horsburgh; Richard Waddell; Bernard F Cole; Jenni M Vuola; Susan Tvaroha; Barry Kreiswirth; Kisali Pallangyo; C Fordham von Reyn Journal: Clin Infect Dis Date: 2005-04-12 Impact factor: 9.079
Authors: Serena P Koenig; Cynthia Riviere; Paul Leger; Patrice Joseph; Patrice Severe; Kea Parker; Sean Collins; Erin Lee; Jean W Pape; Daniel W Fitzgerald Journal: Clin Infect Dis Date: 2009-03-15 Impact factor: 9.079
Authors: Graeme Meintjes; Stephen D Lawn; Fabio Scano; Gary Maartens; Martyn A French; William Worodria; Julian H Elliott; David Murdoch; Robert J Wilkinson; Catherine Seyler; Laurence John; Maarten Schim van der Loeff; Peter Reiss; Lut Lynen; Edward N Janoff; Charles Gilks; Robert Colebunders Journal: Lancet Infect Dis Date: 2008-08 Impact factor: 25.071
Authors: Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger Journal: Lancet Date: 2006-03-11 Impact factor: 79.321
Authors: A Gupta; J Mbwambo; I Mteza; S Shenoi; B Lambdin; C Nyandindi; B I Doula; S Mfaume; R D Bruce Journal: Int J Tuberc Lung Dis Date: 2014-07 Impact factor: 2.373
Authors: G Mtwangambate; S E Kalluvya; B R Kidenya; R Kabangila; J A Downs; L R Smart; D W Fitzgerald; R N Peck Journal: Diabet Med Date: 2013-11-18 Impact factor: 4.359
Authors: Bahati M K Wajanga; Robert N Peck; Samuel Kalluvya; Daniel W Fitzgerald; Luke R Smart; Jennifer A Downs Journal: PLoS One Date: 2014-02-14 Impact factor: 3.240
Authors: Yasmeen Hanifa; Katherine L Fielding; Violet N Chihota; Lungiswa Adonis; Salome Charalambous; Nicola Foster; Alan Karstaedt; Kerrigan McCarthy; Mark P Nicol; Nontobeko T Ndlovu; Edina Sinanovic; Faieza Sahid; Wendy Stevens; Anna Vassall; Gavin J Churchyard; Alison D Grant Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240